Sarcomatrix Therapeutics Appoints Dr. Jeff Myers as Chief Medical Officer
Seasoned biopharma leader and former cardiothoracic surgeon steps in as company moves lead candidate S-969 toward IND submission RENO, NV, UNITED STATES, July 17, 2026 /EINPresswire.com/ — Sarcomatrix Therapeutics, a...
By Samuel Reed · Jul. 22, 2026